通过STAT蛋白质对干扰素α和干扰素β刺激的基因表达中MAP激酶 (ERK2) 活性的要求
M David1, E Petricoin, C Benjamin
1Division of Cytokine Biology, Center for Biologics Evaluation and Research, Bethesda, MD 20892, USA.
概括
中原激活蛋白激酶 (MAPK) 与干扰素受体相互作用,调节早期的基因激活. 这一发现揭示了MAPK.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 干扰子 (IFN) 通过STAT蛋白酸化激活早期反应基因.
- 调节IFN信号的精确机制需要进一步阐明.
研究的目的:
- 调查基激活蛋白激酶 (MAPK) 在干扰素α/β (IFN-α/β) 信号传递中的作用.
- 为了确定MAPK是否在响应IFN时调节Jak-STAT通路.
主要方法:
- 在MAPK (ERK2) 和IFN-α/β受体之间的体外和体内相互作用研究.
- 用IFN-β进行细胞治疗,以评估MAPK和Stat1α酸化和共免疫沉.
- 使用主导负MAPK表达的IFN-β诱导转录的分析.
主要成果:
- 发现基激活蛋白激酶 (MAPK),特别是ERK2,与IFN-α/β受体相互作用.
- IFN-β治疗诱导了铁酸酸化和MAPK的激活.
- 在IFN-β刺激后,MAPK和Stat1α共免疫降落.
- 用主导负构造抑制MAPK信号,阻止IFN-β诱导的转录.
结论:
- MAPK在IFN-α和IFN-β信号通路中起着调节作用.
- MAPK修改了Jak-STAT级联,影响IFN的早期反应基因的激活.
相关概念视频
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...


